OKYO Pharma Limited Increase Decrease Through Foreign Exchange Financial Assets
OKYO Pharma Limited (OKYO) reported Increase Decrease Through Foreign Exchange Financial Assets of -$5.83 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-18.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets · last filed 2025-07-18
| Period end | Increase Decrease Through Foreign Exchange Financial Assets 12 month |
|---|---|
| 2025-03-31 | -$5.83K 20-F · filed 2025-07-18 |
| 2024-03-31 | -$5.42K 20-F · filed 2025-07-18 |
| 2023-03-31 | $2.78K 20-F · filed 2025-07-18 |
| 2022-03-31 | -$3.98K 20-F · filed 2024-08-13 |
| 2021-03-31 | $135.00 20-F · filed 2023-08-15 |
| 2020-03-31 | -$32.50K 20-F · filed 2022-08-15 |